An improved reporter identifies ruxolitinib as a potent and cardioprotective CaMKII inhibitor.

An improved reporter identifies ruxolitinib as a potent and cardioprotective CaMKII inhibitor. Sci Transl Med. 2023 06 21; 15(701):eabq7839.

View in: PubMed